Recently, we have described that tyrosine phosphorylation of CD133 (p‐CD133) contributes to aggressive tumor growth of colon cancer cells through the activation of the pro‐oncogenic AKT pathway 37. This evidence concerns the gene PROM1 and malignant colon neoplasm.